相似文献
1
Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2.
Int J Lab Hematol. 2020 Oct;42(5):e211-e212. doi: 10.1111/ijlh.13244. Epub 2020 May 22.
2
von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients.
Br J Haematol. 2021 Mar;192(6):1097-1100. doi: 10.1111/bjh.17216. Epub 2020 Dec 24.
3
Obstetric outcomes in pregnant COVID-19 women: the imbalance of von Willebrand factor and ADAMTS13 axis.
BMC Pregnancy Childbirth. 2022 Feb 21;22(1):142. doi: 10.1186/s12884-022-04405-8.
4
Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid-19 patients.
Int J Lab Hematol. 2021 Aug;43(4):O152-O155. doi: 10.1111/ijlh.13476. Epub 2021 Jan 27.
5
Contribution of the von Willebrand factor/ADAMTS13 imbalance to COVID-19 coagulopathy.
Am J Physiol Heart Circ Physiol. 2022 Jan 1;322(1):H87-H93. doi: 10.1152/ajpheart.00204.2021. Epub 2021 Dec 10.
6
Vascular activation is a strong predictor of mortality in coronavirus disease 2019 patients on the ICU.
Blood Coagul Fibrinolysis. 2021 Jun 1;32(4):290-293. doi: 10.1097/MBC.0000000000001007.
7
Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases.
World J Gastroenterol. 2017 Jul 14;23(26):4796-4805. doi: 10.3748/wjg.v23.i26.4796.
8
Interrelationship between ADAMTS13 activity, von Willebrand factor, and complement activation in remission from immune-mediated trhrombotic thrombocytopenic purpura.
Br J Haematol. 2020 Apr;189(1):e18-e20. doi: 10.1111/bjh.16415. Epub 2020 Feb 17.
9
Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage.
Thromb Haemost. 2017 Apr 3;117(4):691-699. doi: 10.1160/TH16-11-0834. Epub 2017 Jan 19.
10
von Willebrand factor proteolysis by ADAMTS-13 in patients on left ventricular assist device support.
J Heart Lung Transplant. 2017 Apr;36(4):477-479. doi: 10.1016/j.healun.2017.01.010. Epub 2017 Jan 13.
引用本文的文献
1
COVID-Induced Thrombotic Thrombocytopenic Purpura: A Case Report and Treatment-Focused Review.
Cureus. 2024 Mar 30;16(3):e57252. doi: 10.7759/cureus.57252. eCollection 2024 Mar.
2
Palmitate Stimulates Expression of the von Willebrand Factor and Modulates Toll-like Receptors Level and Activity in Human Umbilical Vein Endothelial Cells (HUVECs).
Int J Mol Sci. 2023 Dec 23;25(1):254. doi: 10.3390/ijms25010254.
3
Coagulopathy and thromboembolic events a pathogenic mechanism of COVID-19 associated with mortality: An updated review.
J Clin Lab Anal. 2023 Jun;37(11-12):e24941. doi: 10.1002/jcla.24941. Epub 2023 Jul 11.
4
Von Willebrand factor and the thrombophilia of severe COVID-19: evidence from autopsies.
Res Pract Thromb Haemost. 2023 May;7(4):100182. doi: 10.1016/j.rpth.2023.100182. Epub 2023 May 18.
5
Endotheliopathy in Acute COVID-19 and Long COVID.
Int J Mol Sci. 2023 May 4;24(9):8237. doi: 10.3390/ijms24098237.
6
COVID-19 and Sickle Cell Disease: Two Independent Risk Factors for Venous Thromboembolism.
Cureus. 2023 Apr 6;15(4):e37226. doi: 10.7759/cureus.37226. eCollection 2023 Apr.
7
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells.
Viruses. 2023 Jan 24;15(2):332. doi: 10.3390/v15020332.
8
Role of the extracellular matrix in COVID-19.
World J Clin Cases. 2023 Jan 6;11(1):73-83. doi: 10.12998/wjcc.v11.i1.73.
9
Mild-to-Moderate COVID-19 Convalescents May Present Pro-Longed Endothelium Injury.
J Clin Med. 2022 Oct 31;11(21):6461. doi: 10.3390/jcm11216461.
10
Severity of SARS-CoV-2 infection is associated with high numbers of alveolar mast cells and their degranulation.
Front Immunol. 2022 Sep 26;13:968981. doi: 10.3389/fimmu.2022.968981. eCollection 2022.
本文引用的文献
1
Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2.
Int J Lab Hematol. 2020 Jun;42 Suppl 1(Suppl 1):19-20. doi: 10.1111/ijlh.13230.
2
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
3
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.
J Thromb Haemost. 2020 Jun;18(6):1421-1424. doi: 10.1111/jth.14830. Epub 2020 May 6.
4
von Willebrand factor/ADAMTS13 ratio at presentation of acute ischemic brain injury is predictive of outcome.
Blood Adv. 2020 Jan 28;4(2):398-407. doi: 10.1182/bloodadvances.2019000979.
5
Variation of endothelium-related hemostatic factors during sepsis.
Microcirculation. 2018 Nov;25(8):e12500. doi: 10.1111/micc.12500. Epub 2018 Oct 10.
6
TTP-like syndrome: novel concept and molecular pathogenesis of endotheliopathy-associated vascular microthrombotic disease.
Thromb J. 2018 Aug 11;16:20. doi: 10.1186/s12959-018-0174-4. eCollection 2018.
7
Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy.
Thromb J. 2018 Jul 11;16:14. doi: 10.1186/s12959-018-0168-2. eCollection 2018.
8
Inflammation, von Willebrand factor, and ADAMTS13.
Blood. 2018 Jul 12;132(2):141-147. doi: 10.1182/blood-2018-02-769000. Epub 2018 Jun 4.
9
The role of ADAMTS-13 in the coagulopathy of sepsis.
J Thromb Haemost. 2018 Apr;16(4):646-651. doi: 10.1111/jth.13953. Epub 2018 Feb 2.
10
The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy.
Mediators Inflamm. 2017;2017:5620314. doi: 10.1155/2017/5620314. Epub 2017 May 28.
Zotero 插件